LAICON2020 : National : Chennai

Hotel Le Royal Meridien

Final Scientific Program

Day 1 February 8th, 2020, Saturday

10.00 – 10.30 amRegistration & Tea 
10.30 – 10.45 amInauguration, Introduction of LAI and lighting of the KuthuVilakku
Joint Session with API Chennai Chapter
10.45 – 1.00 pmWorkshops on Lipids for Practitioners: Real World Scenario
[ 12 minutes talk + 3 minutes discussion]
  1. 56 year old male, diabetic, post PCI, LDL 64 mg%, TG 325 mg% – Dr.S N Narasingan
  2. Post PCI, LDL on target but HDL -C 25 mg% – Dr.D.Prabhakar
  3. Post Intervention – LDL C – 49 mg% – develops peripheral vascular disease. What to do? – Dr.RamanPuri
  4. 29 year old post PCI develops ischemic CVA in one month- What are we missing? – Dr.Ajith Mullaseri
  5. >13 year old girl with LDL 560 mg %– What strikes you and how do you strike it? – Dr.Devaki Nair
  6. 34 year old male with routine check-up has LDL of 196 mg% – with a strong family history of premature coronary artery disease and death – Dr.Paul Barton Duell (USA)
  7. 37 year old asymptomatic premenopausal female with a BMI of 31 kg/m2and a waist circumference of 100 cm who has FBS 104 mg%. HbA1c% : 6.4 % , Total cholesterol = 215 ,HDL 35 mg%, TGL 208 and LDL = 138, Non-HDL C 180, VLDL C = 42 – Dr.Ezhilan
  8. 50 year old diabetic female,with microalbuminuria and retinopathy, no macrovascular disease, LDL = 85 mg% – Dr.Edwin Fernando
  9. Lecithin – Cholesterol AcylTransferase [LCAT] deficiency with CKD : 2 Case reports – Dr.N.Gopalakrishnan
1.00 -1.20 pmChair : Dr.S.Manoj, Dr.Vimal Mehta, Dr.K.Rajendran , Dr.Swamikannu
“PCSK9: Latest Clinical Trial Data and Which Patients Benefit Most? – Dr. Nathan D. Wong (USA)
 
1.20 -1.50 pm[ 12 min talk with 3 min discussion ]
Chair : Dr.G.Sengottuvelu, Dr.E.Prabhu, Dr. P.Paranthaman, Dr, Sundaramurthy
Endothelium in health and Disease –Dr. Guruprasad
Role of Glycated proteins in Atherogenesis –Dr. A. Muruganathan
 
1.50 – 2.50 pmLUNCH BREAK 
2.50 – 4.10 pmControversies In Lipidology [ 12 min talk. = 8 min final discussion ]
Chair : Dr.Ajith Mullaseri , Dr.Anand Moses, Dr. S.Venkatesan, Dr.S.Shanmugasundarum , Dr.S.Tito
  1. Fasting vs non-fasting lipid profile Dr.Nathan D.Wong (USA)
  2. Fibrates – dead or alive? Dr. Altamash
  3. HDL -C – is it the end of the road? Dr.Krishna Seshadri
  4. Omega -3 fatty acids. Are all preparations the same? Dr.Jeyashree Gopal
  5. Lowering LDL C < 30 mg% Dr.Sarat Chandra 6. Non-HDL C / Triglyceride and CV risk Dr.S.N.Narasingan
 
4.10 – 5.30 p.mDialogue – Too Many Guidelines Too much of Confusion – What’s the consensus? [10 minutes talk each and 20 minutes discussion at the end with audience interaction]
Moderator : Dr.S.S.Iyengar, Dr.Vimal Mehta, Dr.Madhur Yadav
  1. ACC AHA Guidelines – 2018 – Dr.Paul Barton Duell (USA)
  2. European Guidelines – 2019 – Dr. Nathan D. Wong (USA)
  3. ADA & AACE guidelines – 2019 – Dr. Usha Sriram
  4. LAI guidelines: Journey so far – Dr. Raman Puri
  5. Lowering LDL C < 30 mg% Dr.Sarat Chandra 6. Non-HDL C / Triglyceride and CV risk Dr.S.N.Narasingan
 
5.30 – 5.50 pm[15 min talk +5 min discussion ]
Chair : Dr. Dharmarajan, Dr. Justin Paul, Mrs. J.Jayavani
Low Carbohydrate and very low carbohydrate including ketogenic diets – Unravelling the puzzle – Dr. G.B.Sattur
 
5.50 to 6.50 pm[ 8 min talk + 2 min discussion ] Non Statin, Non PCSK9i – LDL Lowering – ONTARGET session
Chair : Dr.M.S.Ravi, Dr.Devaki Nair, Dr.Gowrishankar, Dr.R.P. Rajesh, Dr.Raghunandhan, Dr.K.Rajalakshmi
  1. Oligonucleotide Dr. S.Venkatesan
  2. Mipomersan Dr. Manokar P.
  3. Lometapide Dr. Vimal Mehta
  4. .LDL apharesis Dr. Paul Barton Duell
  5. Bempedoic acid Dr. Madhur yadav
  6. Ezetemibe Dr. Sundar Hariharan
 
6.50 – 7.05 pm[ 12 min + 3 min discussion]
Chair : Dr.C.Sridhar, Dr.T.Ravindran, Dr.E.Prabhu
Role of Imaging in Hypercholesterolemia – Dr.Mahapatra
 
7.05 – 7.25 pm[ 15 min + 5 min discussion]
Chair : Dr. P. S .Mohanamurugan ,Dr.C.Hariharan, Dr.S.Chandrasekar Saroglitazaar – Make in India – Current approach in lipid lowering – Dr.
 
7.10 – pm onwards[ 15 min + 5 min discussion]
Chair : Instrumental music and unwind.
 
DAY 2 – 9/2/2020 – SUNDAY [ Joint Session with CSI, Chennai Chapter ]
7.30 – 8.30 amBreakfast Session
Chair : Dr.MS Ravi, Dr.Vijay Viswanathan, Dr. P. Mohanamurugan, Dr.K. Kannan,
[ Each talk for 15 minutes with 5 minutes Discussion ]
 
8.30 to 8.50 amTICAGRELOR – NEW Data, NEWER Evidence : From evidence to Practice – Dr.Y.V.C.Reddy 
8.50 – 9.10 amPanel Discussion on Heart Failure – Focus ON ARNI – Dr. Asha Mahilmaran 
9.10 – 9.30 amPanel Discussion on SGLT2i – Cardiac or Diabetic drug? – Dr.D.Prabhakar 
9.30 – 10.15 amPanel discussion on nonpharmacological measures in lipid lowering
ModeratorsDr.Sattur & Dr.Justin Paul
Panelists
  1. Dr.Manish Bansal
  2. Dr.Meenakshi Bajaj
  3. Dr.Jaishankar
  4. Dr.Ezhilan
 
10.15 – 11.00 amHOT from the GRILL [8 min talk + discussion in the end ]
ChairDr.T.V.Devarajan, Dr.R.Alagesan, Dr.S.Vaidhyanathan, Dr.Sowmiya Jaishankar
  1. Coronary Calcium Score Dr. S.Shanmugasundarum
  2. CIMT and Carotid Ultrasound Dr. R.Ravikumar
  3. LP(a) Dr. Ajith Mullaseri
  4. Apolipoprotein B Dr. Manoj
 
11.00 to 11.40 am[10 min each and 10 min common discussion ]
Familial Hypercholestrolemia
ChairDr.Wong, Dr.Barton Duell, Dr.Ajith Mullaseri
  1. Familial Hypercholesrolemia Dr. Devaki Nair
  2. Genetic studies – What is feasible in FH –Dr.Prashanth
  3. LAI – FH registry –Dr.SS Iyengar
 
11.40 – 12. 30 pmGathering the evidence and focusing on lAI recommendation 2017 only (8 min talk + 2 min discussion)
ChairDr.Edwin Fernando, Dr.Sadanandan, Dr.A.Aravind, Dr. Altamash, Dr.Paranthaman, Dr Sonika Puri ( USA)
  • Dyslipidemia and CKDDr.Sonalika
  • Dyslipidemia and Stroke –Dr.Suresh Kumar
  • Dyslipidemia and Heart Failure –Dr.U.Ilayaraja
  • DHIV and dyslipidemia: Case Based Discussion –Dr. D.Suresh Kumar
  • Statins and NAFLD –Dr. T.S.Chandrasekar
 
12.30 – 1.10 pmRapid Fire Session – Statin Intolerance
[ 8 min x 4 = 32 + 8 min discussion = 40 minutes ]
ChairDr.K.Kannan, Dr.Madhur Yadav, Dr.R.S.Hariharan , Dr.Sowmiya Jaishankar
  1. SAMSDr.Usha Sriram
  2. New onset DiabetesDr.S.S.Lakshmanan
  3. Cognitive dysfunction and NeuropathyDr.Suresh Kumar
  4. LiverDr.P.Basumani
 
1.10 – 1.40 pmLAI guideline session
ChairDr.SS.Iyengar, Dr.K.Shanmugam, Dr.S.Chandrasekar, Dr. Shanmugasundarum
LAI 2016 & 2017 Consensus statement – 15 minutes – Dr.Manish Bansal
[ Part I & II ]
LAI 2019 consensus statement – What’s new? 15 min – Dr.Raman Puri
[ Part III 2019/2020 ]
 
1.40 to 2.30 pmSymposium on PCSK9 inhibitors
[15 minutes each + 5 minutes discussion at the end ]
Chair Dr.Nathan D.Wong, Dr.Vimal Mehta & Dr. Paul Barton Duell
  1. Development of PCK9i – The need and the evolution – Dr Ajit Menon
  2. PCSK9i trials and Indications for clinical use – Dr B B Chanana
  3. Indian experience on Evolocumab – Dr P L N
 
2.30 pmClosing with Lunch